FDA Inspection 635463 — Manhattan Reproductive Medicine, PC

Manhattan Reproductive Medicine, PC — FEI 3004753417

The FDA completed an inspection of Manhattan Reproductive Medicine, PC on January 14, 2010 in New York, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 14, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
New York, NY (United States)

Citations

IDCFRDescription
1222121 CFR 1271.47(a)Procedures for all other requirements
1224721 CFR 1271.55(d)(2)Accurate, indelible, legible